Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TENET HEALTHCARE CORP Director's Dealing 2021

Jan 5, 2021

30374_dirs_2021-01-05_8ba98118-8ea6-4b26-8e56-912005761fcd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TENET HEALTHCARE CORP (THC)
CIK: 0000070318
Period of Report: 2020-12-31

Reporting Person: Rittenmeyer Ronald A (Director, Executive Chairman and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-31 Common Stock M 62908 Acquired 612876 Direct
2020-12-31 Common Stock F 21175 $39.93 Disposed 591701 Direct
2020-12-31 Common Stock M 32701 Acquired 624402 Direct
2020-12-31 Common Stock F 12868 $39.93 Disposed 611534 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-31 2019 February Restricted Stock Units $ M 62908 Disposed Common Stock (62908) Direct
2020-12-31 2020 February Restricted Stock Units $ M 32701 Disposed Common Stock (32701) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 15000 Indirect

Footnotes

F1: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The seventh vesting date occurred on December 31, 2020, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 125,816 restricted stock units are shown in Table II.

F2: Restricted stock units convert into common stock on a one-for-one basis.

F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

F4: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The third vesting date occurred on December 31, 2020, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 261,610 restricted stock units are shown in Table II.

F5: Restricted stock units are settled in shares of the Company's common stock upon vesting.